Ryan Cohlhepp
Fortune : 5 M $ au 31/07/2026
Fortune : 5 M $ au 31/07/2026
Ryan Cohlhepp is President, Chief Operating Officer & Director at Bicara Therapeutics, Inc. since 2024.
Previously, Dr. Cohlhepp was Senior Vice President-Operations at Rheos Medicines, Inc. from 2018 to 2020.
Dr. Cohlhepp earned a doctorate from Purdue University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BICARA THERAPEUTICS INC. 0,28 % | 10/08/2026 | 181 641 ( 0,28 % ) | 5 M $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BICARA THERAPEUTICS INC. | President | 01/10/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Directeur des opérations | 01/10/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rheos Medicines, Inc.
Rheos Medicines, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease | Health Technology |
Bicara Therapeutics, Inc.
Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national